Simplify Asset Management Inc. Raises Stock Position in LivaNova PLC (NASDAQ:LIVN)

Simplify Asset Management Inc. lifted its stake in shares of LivaNova PLC (NASDAQ:LIVN) by 67.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,346 shares of the company’s stock after buying an additional 5,782 shares during the quarter. Simplify Asset Management Inc.’s holdings in LivaNova were worth $754,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Primecap Management Co. CA raised its position in LivaNova by 0.7% in the 2nd quarter. Primecap Management Co. CA now owns 5,981,200 shares of the company’s stock valued at $327,889,000 after purchasing an additional 44,049 shares during the last quarter. Vanguard Group Inc. increased its stake in LivaNova by 3.5% in the 1st quarter. Vanguard Group Inc. now owns 1,832,987 shares of the company’s stock valued at $102,537,000 after buying an additional 62,480 shares during the period. Point72 Asset Management L.P. increased its stake in LivaNova by 204.3% in the 2nd quarter. Point72 Asset Management L.P. now owns 1,285,636 shares of the company’s stock valued at $70,479,000 after buying an additional 863,157 shares during the period. Victory Capital Management Inc. increased its stake in LivaNova by 16.6% in the 3rd quarter. Victory Capital Management Inc. now owns 935,102 shares of the company’s stock valued at $49,130,000 after buying an additional 133,401 shares during the period. Finally, Magnetar Financial LLC increased its stake in LivaNova by 8.1% in the 2nd quarter. Magnetar Financial LLC now owns 814,452 shares of the company’s stock valued at $44,648,000 after buying an additional 61,114 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on LIVN shares. Stifel Nicolaus upped their price target on shares of LivaNova from $70.00 to $72.00 and gave the stock a “buy” rating in a research note on Thursday, July 25th. The Goldman Sachs Group initiated coverage on shares of LivaNova in a research report on Friday, October 4th. They set a “buy” rating and a $65.00 target price for the company. Baird R W raised shares of LivaNova from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, September 17th. Needham & Company LLC reaffirmed a “buy” rating and issued a $75.00 price objective on shares of LivaNova in a research report on Tuesday. Finally, Mizuho lowered their price objective on shares of LivaNova from $80.00 to $70.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. One investment analyst has rated the stock with a hold rating, five have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, LivaNova presently has a consensus rating of “Buy” and a consensus target price of $69.17.

LivaNova Stock Performance

LIVN traded down $0.33 during trading hours on Friday, hitting $51.99. 45,564 shares of the stock were exchanged, compared to its average volume of 616,851. The stock has a 50-day simple moving average of $51.67 and a 200-day simple moving average of $52.98. LivaNova PLC has a 12 month low of $42.75 and a 12 month high of $64.47. The stock has a market cap of $2.82 billion, a price-to-earnings ratio of 123.95 and a beta of 1.01. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87.

LivaNova Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.